Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting Fear Memory by Disrupting the Process of Reconsolidating: A New Intervention for Panic Disorder

NCT02631694 is registered in ClinicalTrials.gov with VU University of Amsterdam as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02631694 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting Fear Memory by Disrupting the Process of Reconsolidating: A New Intervention for Panic Disorder
Lead sponsor
VU University of Amsterdam
Phase
Phase 2
Overall status
Unknown status
Start date
April 30, 2016
Completion date
September 30, 2019
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.